REDITREX Trademark

Trademark Overview

On Tuesday, November 28, 2017, a trademark application was filed for REDITREX with the United States Patent and Trademark Office. The USPTO has given the REDITREX trademark a serial number of 87700133. The federal status of this trademark filing is REGISTERED as of Tuesday, April 14, 2020. This trademark is owned by Cumberland Pharmaceuticals Inc.. The REDITREX trademark is filed in the Pharmaceutical Products category with the following description:

Anti-arthritic compositions and preparations; analgesic compositions and preparations; chemical preparations for pharmaceutical or medical purposes for treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the prevention and treatment of auto immune diseases and disorders; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including arthritis, juvenile idiopathic arth...
reditrex

General Information

Serial Number87700133
Word MarkREDITREX
Filing DateTuesday, November 28, 2017
Status700 - REGISTERED
Status DateTuesday, April 14, 2020
Registration Number6034222
Registration DateTuesday, April 14, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 4, 2018

Trademark Statements

Goods and ServicesAnti-arthritic compositions and preparations; analgesic compositions and preparations; chemical preparations for pharmaceutical or medical purposes for treatment of auto immune diseases and inflammatory diseases; medicinal preparations for treatment of inflammatory diseases and auto immune diseases; pharmaceutical preparations and substances for the treatment of pain and inflammation; pharmaceutical preparations for the prevention and treatment of auto immune diseases or disorders; pharmaceutical preparations for the prevention and treatment of auto immune diseases and disorders; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including rheumatoid arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases; pharmaceutical preparations for the treatment of auto immune diseases and inflammatory diseases, including arthritis, juvenile idiopathic arthritis and psoriasis; pharmaceutical products for the treatment of joint disease
Pseudo MarkREADY TREKS
Pseudo MarkREDI TREX

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 8, 2017
Primary Code005
First Use Anywhere DateWednesday, October 9, 2019
First Use In Commerce DateWednesday, October 9, 2019

Trademark Owner History

Party NameNORDIC GROUP B.V.
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressHOOFDDORP 2132WT
NL
Party NameCumberland Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameCumberland Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameCumberland Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events

Event DateEvent Description
Tuesday, August 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 29, 2023TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, August 29, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 29, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 23, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, January 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 14, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, March 10, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, March 9, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 26, 2020ASSIGNED TO EXAMINER
Wednesday, February 12, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 11, 2020TEAS REQUEST FOR RECONSIDERATION RECEIVED
Tuesday, January 7, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, January 7, 2020FINAL REFUSAL E-MAILED
Tuesday, January 7, 2020SU - FINAL REFUSAL - WRITTEN
Friday, December 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 17, 2019ASSIGNED TO LIE
Thursday, December 5, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 26, 2019NON-FINAL ACTION E-MAILED
Tuesday, November 26, 2019SU - NON-FINAL ACTION - WRITTEN
Saturday, November 9, 2019STATEMENT OF USE PROCESSING COMPLETE
Tuesday, October 29, 2019USE AMENDMENT FILED
Saturday, November 9, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 29, 2019TEAS STATEMENT OF USE RECEIVED
Wednesday, April 17, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 15, 2019SOU EXTENSION 1 GRANTED
Monday, April 15, 2019SOU EXTENSION 1 FILED
Monday, April 15, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, October 30, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 4, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 15, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 23, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 16, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, July 16, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 16, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 29, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 29, 2018NON-FINAL ACTION E-MAILED
Monday, January 29, 2018NON-FINAL ACTION WRITTEN
Monday, January 22, 2018ASSIGNED TO EXAMINER
Friday, December 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 1, 2017NEW APPLICATION ENTERED

Related Keywords

reditrex diseases preparations treatment auto immune pharmaceutical inflammatory arthritis including disorders